Ovarian cancer, often called the silent killer, presents one of the most serious health threats women face globally. Its ...

According to the Centers for Disease Control and Prevention ( CDC ), ovarian cancer may cause vaginal bleeding, pelvic pain, ...

Four in every 10 cancer patients treated with chemotherapy develop severe peripheral nerve pain, a new review suggests.

Hyperthermic intraperitoneal chemotherapy (HIPEC) is an innovative treatment approach used in the management of ovarian cancer, particularly in advanced stages. This technique involves delivering ...

Ovarian cancer, a deadly gynecologic malignancy, has seen a significant shift in its treatment paradigm with the introduction ...

certain chemotherapy drugs can also raise risk for a secondary cancer. Chemotherapy for ovarian cancer typically includes a platinum-based drug, such as cisplatin or carboplatin. Your treatment ...

One reason is the fact that much research related to ovarian cancer has focused on strategies combining chemotherapy with ...

Chemotherapy has been known to cause damage to peripheral nerves, and sometimes the pain is chronic and severe enough that chemotherapy doses are reduced or discontinued. But prior research has not ...

Worldwide, cancer chemotherapy is linked to persistent severe peripheral nerve pain (neuropathy) for around 4 in every 10 patients treated with these drugs, suggests a pooled data analysis of the ...

Analyst Andrew Fein of H.C. Wainwright reiterated a Buy rating on Zentalis Pharmaceuticals (ZNTL – Research Report), reducing the price target ...

Results from DENALI Part 1b show an Objective Response Rate (ORR) of ~35% in response-evaluable, heavily-pretreated patients with Cyclin E1+ ...

Subgroup analyses showed that patients treated with platinum-based agents and taxanes had the highest prevalence of chronic ...